← Leaderboards
Alexis R. Demonbreun
Northwestern University At Chicago
$3,554,574
Attributed
$7,109,148
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$7,109,148 · 6
By mechanism
R01$3,992,913 · 3
UG3$2,060,218 · 1
UH3$616,017 · 1
R21$440,000 · 1
Top collaborators
- Elizabeth M Mcnally10 shared
- Kay F Macleod1 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Melissa A. Simon$40,197,785
- Tanya Simuni Simuni$20,339,132
- Lifang Hou$15,184,823
- David Victorson$7,754,576
- James William Griffith$7,291,641
Others in their field
Other Rising Stars on “Proteins”
- Suma Babu · Massachusetts General Hospital$18,972,058
- Sabrina Paganoni · Massachusetts General Hospital$18,972,058
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Research focus
ProteinsMuscular DystrophiesGeneticInjuryCellsTissuesMuscular AtrophyMuscleSignal TransductionIn VivoDisease ProgressionMuscle FunctionBindingAntibodiesLinkMembraneGenesExtracellular MatrixFibrosisImpairmentTransforming Growth Factor BetaDefectPredispositionInjured
Grant awards (11)
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$706,992
R01 · FY2025 · HL
Role of BNIP3 and mitophagy in muscle atrophy and cancer cachexia$698,076
R01 · FY2025 · CA
Development of anti-LTBP4 as a biologic to treat Limb Girdle Muscular Dystrophy 2C$440,000
R21 · FY2025 · TR · contact PI
Mechanisms of resealing and rebuilding in muscle repair$400,000
R01 · FY2025 · NS
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$692,853
R01 · FY2024 · HL
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases$616,017
UH3 · FY2024 · NS · contact PI
Mechanisms of resealing and rebuilding in muscle repair$388,000
R01 · FY2024 · NS
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$706,992
R01 · FY2023 · HL
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases$565,309
UG3 · FY2023 · NS · contact PI
Mechanisms of resealing and rebuilding in muscle repair$400,000
R01 · FY2023 · NS
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases$1,494,909
UG3 · FY2022 · NS · contact PI